Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer

This publication has 34 references indexed in Scilit:

• Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?
  Prostate Cancer and Prostatic Diseases, 2001
• Bicalutamide Monotherapy Versus Flutamide Plus Goserelin in Prostate Cancer Patients: Results of an Italian Prostate Cancer Project Study
  Journal of Clinical Oncology, 1999
• Bicalutamide dosages used in the treatment of prostate cancer
  The Prostate, 1999
• Treatment options for early prostate cancer
  Urology, 1998
• Androgen Deprivation for Prostatic Carcinoma: A Rationale for Choosing Components
  International Journal of Urology, 1998
• A Randomised Comparison of ‘Casodex’TM (Bicalutamide) 150 mg Monotherapy versus Castration in the Treatment of Metastatic and Locally Advanced Prostate Cancer
  European Urology, 1998
• Prostate Cancer
  Drugs & Aging, 1998
• Quality of Life, Sexual Functioning and Sex Role Identity After Surgical Orchidectomy in Patients with Prostatic Cancer
  Scandinavian Journal of Urology and Nephrology, 1995
• Endocrine profiles during administration of the new non‐steroidal anti‐androgen Casodex in prostate cancer
  Clinical Endocrinology, 1994
• Patients' choice of treatment in stage D prostate cancer
  Published by Elsevier ,1989